US Prostate Cancer Nuclear Medicine Diagnostics Market is expected to reach US$ 431.76 Million by 2027 with CAGR of 10.6%.

If your doctor suspects prostate cancer, you may use nuclear medicine imaging to make the diagnosis. Nuclear medicine, a type of radiological imaging, is a useful tool for detecting and treating prostate cancer. This is a type of diagnostic imaging that helps radiologists determine the stage of cancer.

US prostate cancer nuclear medicine diagnostics market was valued at US$ 194.47 million in 2020 and is expected to grow at a CAGR of 10.6% from 2020 to 2027 to reach US$ 431.76 million by 2027.

The pharmaceutical industry discovers, develops, manufactures, and sells medicines or drugs for use as medicines administered to patients for the treatment, vaccination, or alleviation of symptoms of patients. Pharmaceutical companies carry generic or branded medicines and medical devices.

The US Prostate Cancer Nuclear Medicine Diagnostics market is growing along with the healthcare industry, but the market is likely to slow down its growth due to the shortage of skilled professionals, suggests the Business Market Insights report.

The Business Market Insights subscription helps clients understand the ongoing market trends, identify opportunities, and make informed decisions through the reports in the Subscription Platform. The Industry reports available in the subscription provide an in-depth analysis on various market topics and enable clients to line up remunerative opportunities. The reports provide the market size & forecast, drivers, challenges, trends, and more.

Get free trial subscription and gain instant access to our market research reports at https://www.businessmarketinsights.com/TIPRE00009805/request-trial

The US prostate cancer nuclear medicine diagnostics market, by PET product, is segmented into F-18, C-11, and Ga68-PSMA. The F-18 segment held the largest share of the market in 2019. However, Ga68-PSMA is estimated to register the highest CAGR in the market during the forecast period due to factors such as the rising prevalence of prostate cancer, technological improvements in diagnosis systems using Ga68-PSMA, and its higher sensitivity and accuracy.

These factors are expected to offer broad growth opportunities in the healthcare industry and this is expected to cause the demand for immunochemistry assays in the market.

Business Market Insights reports focus upon client objectives, use standard research methodologies and exclusive analytical models, combined with robust business acumen, which provides precise and insightful results.

Business Market Insights reports are useful not only for corporate and academic professionals but also for consulting, research firms, PEVC firms, and professional services firms.

US Prostate Cancer Nuclear Medicine Diagnostics - MARKET SEGMENTATION

By Type

• PET
• SPECT

By PET Product

• F-18
• C-11
• Ga68-PSMA

Company Profiles

• Blue Earth Diagnostics Limited
• Progenics Pharmaceuticals, Inc.
• CURIUM
• Telix Pharmaceuticals Ltd.
• NCM-USA LLC
• ABX Advanced Biochemical Compounds GmbH
• Jubilant Radiopharma
• Lantheus Medical Imaging, Inc.
• Advanced Accelerator Applications (Novartis AG)
• Theragnostics

Full Report subscription with pay as per requirement at https://www.businessmarketinsights.com/TIPRE00009805/checkout/basic/single/monthly

 (30-day subscription plans prove to be very cost-effective with no compromise on the quality of reports)

Benefits with Business Market Insights

• One Stop Platform to All the Market Insight Needs
• Avoid Long Purchase Procedures
• Fast and Easy Access
• Cloud-Based Platform
• News Updates
• Ask the Analyst Support
• Pay Monthly Subscription and Access All You Want
• No Compulsion for Yearly Subscription
• Reports Read or Download Access
• Monthly New Reports Added
• Affordable Product, Pay as Per Requirement

About Business Market Insights

Based in New York, Business Market Insights is a one-stop destination for in-depth market research reports from various industries including Technology, Media & Telecommunications, Semiconductor & Electronics, Aerospace & Defense, Automotive & Transportation, Biotechnology, Healthcare IT, Manufacturing & Construction, Medical Device, and Chemicals & Materials. The clients include corporate and academic professionals, consulting, research firms, PEVC firms, and professional services firms.

For Subscription contact

Business Market Insights

Phone : +442081254005
E-Mail : [email protected]

Posted by Rajat Sahni on Thursday July 09 2020, 8:59 AM EDT. All trademarks acknowledged. Filed under Healthcare, Life Sciences, Medical Devices, Pharmaceuticals. Comments and Trackbacks closed. Follow responses: RSS 2.0